doi: 10.1001/archneur.1984.04050170062019.
Neuroendocrinologic findings in patients with untreated Huntington's chorea
- PMID: 6232913
- DOI: 10.1001/archneur.1984.04050170062019
Item in Clipboard
Neuroendocrinologic findings in patients with untreated Huntington's chorea
Arch Neurol.
1984 May.
Abstract
Huntington's chorea (HC) was studied in 14 untreated patients, in six patients receiving long-term neuroleptic treatment, and in four patients after drug withdrawal. Our results showed that patients with HC may be divided into three groups, otherwise clinically indistinguishable, on the basis of growth hormone responsiveness to dopaminergic stimuli. The existence of subpopulations of patients with HC must be considered in further studies on these subjects.
Similar articles
-
Growth hormone and prolactin secretion in Huntington's disease.Life Sci. 1979 Feb 19;24(8):743-9. doi: 10.1016/0024-3205(79)90357-6. Life Sci. 1979. PMID: 155768 No abstract available.
-
Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.Trans Am Neurol Assoc. 1976;101:53-6. Trans Am Neurol Assoc. 1976. PMID: 141763 No abstract available.
-
Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.J Neurol Neurosurg Psychiatry. 1978 Feb;41(2):135-9. doi: 10.1136/jnnp.41.2.135. J Neurol Neurosurg Psychiatry. 1978. PMID: 24678 Free PMC article.
-
Acute treatment of Huntington's chorea with lisuride.J Neurol Sci. 1983 May;59(2):247-53. doi: 10.1016/0022-510x(83)90042-4. J Neurol Sci. 1983. PMID: 6222164 Clinical Trial.
-
Role of tetrabenazine for Huntington's disease-associated chorea.Ann Pharmacother. 2010 Jun;44(6):1080-9. doi: 10.1345/aph.1M582. Epub 2010 May 4. Ann Pharmacother. 2010. PMID: 20442355 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
